StonvexLoading…
StonvexStonvexStonvexCore line items from JL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $39.08M | $28.38M | $38.29M | $38.29M |
Operating Income | $2.40M | $380.30K | $6.23M | $5.53M |
Net Income | $2.59M | $783.66K | $6.66M | $4.48M |
EPS (Diluted) | $0.80 | $0.26 | $2.24 | $0.15 |
Total Assets | $23.45M | $16.89M | $20.61M | Not available |
Total Liabilities | $8.41M | $6.72M | $9.26M | Not available |
Cash & Equivalents | $10.67M | $4.16M | $5.96M | $7.36M |
Free Cash Flow OCF − CapEx | $6.20M | $-1.70M | $1.91M | $5.58M |
Shares Outstanding | 3.76M | 3.14M | 30.00M | 30.00M |